Form 4 for RGEN REPLIGEN CORP
Accepted 2026-05-08 14:48:02 ET · period of report 2026-05-07 · accession 0001193125-26-214293 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-08 14:48 | 2026-05-07 | RGEN | MUIR GLENN P | Dir | M - OptEx | $38.76 | +2,434 | 39.1K | +7% | +$94.3K |
| D | 2026-05-08 14:48 | 2026-05-07 | RGEN | MUIR GLENN P | Dir | M - OptEx | $0.00 | +2,434 | 2,434 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-07 | M | A | 2,434 | $38.76 | 39,056 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-07 | M | A | 2,434 | $0.00 | 2,434 | D | $38.76 · — to 2027-05-18 | 2,434 Common Stock | (F1) This option is fully vested and exercisable. |